Hebei Weimiao Biology Co., LTD 1
Location
  • Producers of Hydroxychloroquine Sulfate with CAS number 747-36-4.

ജൂണ്‍ . 12, 2024 14:30 Back to list

Producers of Hydroxychloroquine Sulfate with CAS number 747-36-4.



Hydroxychloroquine Sulfate CAS 747-36-4 An Overview of Manufacturers and Its Significance Hydroxychloroquine sulfate, with the chemical identity CAS 747-36-4, is a widely recognized pharmaceutical compound that has garnered significant attention in recent times due to its potential therapeutic applications. This derivative of chloroquine is primarily manufactured by several pharmaceutical companies across the globe, each adhering to strict quality standards to ensure its efficacy and safety. Manufacturing hydroxychloroquine sulfate involves a precise process that begins with the synthesis of its active pharmaceutical ingredient (API). The manufacturers, ranging from large multinational corporations to specialized small-scale producers, follow Good Manufacturing Practices (GMP) to guarantee the highest level of purity and consistency in the final product. Major manufacturers of hydroxychloroquine sulfate include companies like Sanofi, Novartis, Zydus Cadila, Ipca Laboratories, and numerous others. These companies have established themselves in the global market through their commitment to research, development, and the production of high-quality APIs. They operate state-of-the-art facilities equipped with advanced technology for the synthesis, purification, and formulation of hydroxychloroquine sulfate. The compound's primary use is in the treatment of autoimmune diseases such as rheumatoid arthritis and lupus erythematosus, where it exhibits immunomodulatory and anti-inflammatory properties. However, it gained extraordinary attention during the COVID-19 pandemic when initial studies suggested it might have potential as a therapeutic agent However, it gained extraordinary attention during the COVID-19 pandemic when initial studies suggested it might have potential as a therapeutic agent However, it gained extraordinary attention during the COVID-19 pandemic when initial studies suggested it might have potential as a therapeutic agent However, it gained extraordinary attention during the COVID-19 pandemic when initial studies suggested it might have potential as a therapeutic agenthydroxychloroquine sulfate cas747-36-4 manufacturers. Although subsequent large-scale clinical trials did not confirm these early findings, the interest in hydroxychloroquine sulfate remains high due to its unique pharmacological profile. The manufacturers of hydroxychloroquine sulfate CAS 747-36-4 play a crucial role in ensuring the availability of this drug worldwide. They are responsible for maintaining a steady supply chain, especially during emergencies, while also investing in research to explore new therapeutic possibilities. Furthermore, they engage in continuous quality control measures to ensure the safety and efficacy of the medication, adhering to international regulatory guidelines like those set by the FDA, EMA, and WHO. In conclusion, hydroxychloroquine sulfate CAS 747-36-4 is a critical compound with a diverse range of applications in medicine. The manufacturers behind its production hold a vital responsibility in the healthcare industry, contributing to the global health landscape through their commitment to quality, research, and accessibility. As scientific understanding evolves, the role of these manufacturers will continue to be instrumental in shaping the future of hydroxychloroquine sulfate as a therapeutic agent.
Share

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


ml_INMalayalam